Hybrid Treatment of Type B Aortic Dissection
Superiority Trial of Type b Aortic Dissection Treatment Combined With Implantation of Bare Metal Stent in Abdominal Part of Aorta Versus Conventional Type b Treatment
1 other identifier
interventional
160
0 countries
N/A
Brief Summary
Authors hypothesize that thoracoabdominal aortic repair combined with bare metal stent implantation is superior over standard thoracoabdominal aortic repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 27, 2016
CompletedFirst Posted
Study publicly available on registry
April 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedSeptember 13, 2017
September 1, 2017
6 years
January 27, 2016
September 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Permanent neurological events
Quantity of permanent neurological events such as stroke and paraplegia by 30th day after procedure.
30 days
Secondary Outcomes (3)
Perioperative bleeding
5 days after procedure
Mortality
6 months
Visceral malperfusion
6 months
Study Arms (2)
Hybrid TAAD repair
EXPERIMENTALThe group includes patients who underwent open thoracoabdominal aortic repair + abdominal stenting.
Conventional TAAD repair
ACTIVE COMPARATORThe group includes patients who underwent classic thoracoabdominal aortic repair with dacron prosthesis.
Interventions
Thoracoabdominal aortic dissection (TAAD) repair + bare aortic stent (Djumbodis) implantation
Thoracoabdominal aortic dissection (TAAD) repair
Eligibility Criteria
You may qualify if:
- Patients with chronic aortic dissection type B
- Aortic size in descending thoracoabdominal aorta (TAA) \> 55 mm
You may not qualify if:
- concomitant cardiac pathology
- concomitant oncology diseases in the last 5 years
- acute aortic dissection
- aortic size in visceral zone \>45 mm
- connectivity tissue diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Alexander M. Chernyavskiy, MD PhD
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health care of Russian Federation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiac surgeon
Study Record Dates
First Submitted
January 27, 2016
First Posted
April 4, 2016
Study Start
January 1, 2013
Primary Completion
January 1, 2019
Study Completion
January 1, 2020
Last Updated
September 13, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share